EORTC-NCI-AACR--20th symposium molecular targets and cancer therapeutics.
Din
Sarah
S
Thomas Reuters, London, UK. sarah.din@thomsonreuters.com
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy; D002100:Cachexia / Q000188:drug therapy / Q000209:etiology; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000037:antagonists & inhibitors; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000235:genetics*; D051736:Proto-Oncogene Proteins c-mdm2 / Q000037:antagonists & inhibitors; D014162:Transfection
D000970:Antineoplastic Agents; D007334:Insulin-Like Growth Factor I; C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2